ASX Share rice
Thu 13 Aug 2020 - 10:01:am (Sydney)

PAA Share Price

PHARMAUST LIMITEDPAAPharmaceuticals, Biotechnology & Life Sciences

PAA Company Information

Name:

PharmAust Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

5/3 Brodie Hall Drive Bentley WA Australia 6102

Phone:

61 8 9202 6814

Exec. Chairman & Acting CEO:

Dr. Roger Aston B.Sc., BSc (Hons), Ph.D.

Chief Scientific Officer:

Dr. Richard Mollard

Exec. Director:

Mr. Robert Charles Bishop

Company Sec. & Director:

Mr. Sam Michael Wright A.C.I.S., M.A.I.C.D., AFin, DipAcc, ACIS, MAICD

Chief Exec. Officer of Epichem Pty Ltd:

Dr. Martine Keenan

Company Overview:

PharmAust Limited operates as a drug discovery and development company in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers in humans and animals. Its lead candidate is Monepantel, which are in Phase II clinical trials for the treatment of cancer. The company also provides highly specialized medicinal and synthetic chemistry services on a contract basis to clients to the drug discovery and pharmaceutical industries. PharmAust Limited is based in Bentley, Australia.

PAA Share Price Information

Shares Issued:

315.60M

Market Capitalisation:

$59.96M

Revenue (TTM):

$4.26M

Revenue Per Share (TTM):

$0.02

Earnings per Share:

$-0.007

Profit Margin:

-0.4572

Operating Margin (TTM):

$-0.44

Return On Assets (TTM):

$-0.12

Return On Equity (TTM):

$-0.24

Quarterly Revenue Growth (YOY):

-0.036

Gross Profit(TTM):

$4.01M

Diluted Earnings Per Share (TTM):

$-0.007

PAA CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-146,725

Change To Liabilities:

$56.19K

Total Cashflow From Investing Activities:

$-146,725

Net Borrowings:

$-101,027

Net Income:

$-1,551,222

Total Cash From Operating Activities:

$-1,554,006

Depreciation:

$172.43K

Change To Inventory:

$-37,801

Change To Account Receivables:

$-10,489

Capital Expenditures:

$146.73K

PAA Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-1,551,222

Net Income:

$-1,551,222

Gross Profit:

$3.34M

Operating Income:

$-2,197,497

Interest Expense:

$47.82K

Total Revenue:

$3.67M

Total Operating Expenses:

$5.53M

Cost Of Revenue:

$333.63K

PAA Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$3.11M

Total Liabilities:

$1.14M

Total Stockholder Equity:

$7.46M

Other Current Liabilities:

$105.60K

Total Assets:

$8.60M

Common Stock:

$51.39M

Other Current Assets:

$58.51K

Retained Earnings:

$-45,839,818

Other Liabilities:

$36.60K

Cash:

$2.09M

Total Current Liabilities:

$0.92M

Short-Term Debt:

$143.38K

Property - Plant & Equipment:

$2.47M

Net Tangible Assets:

$4.35M

Total Current Assets:

$3.02M

Long-Term Debt:

$181.23K

Net Receivables:

$258.84K

Short-Term Investments:

$5.58M

Inventory:

$611.82K

Accounts Payable:

$673.02K

Non Currrent Assets (Other):

$-1

Short-Term Investments:

$5.58

Non Current Liabilities Total:

$217.83K

PAA Share Price History

PAA News

14 May, 2020
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...